Biosynex Stock
Stocks
ALBIO
FR0011005933
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
11:55:00 2026-11-18 EST
|
5-day change | 1st Jan Change | ||
| 0.8040 EUR | -0.74% |
|
-2.43% | +34.90% |
| 10-30 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-26 | Biosynex US Unit Bags $6 Million Award for DPP Biothreat Panel Assay Development | MT |
| Market Cap | 14.93M 16.37M 13.8M 12.46M 23.46M 1.53B 24.39M 167M 65.9M 826M 61.42M 60.13M 2.61B | P/E 2024 |
-0.43x | P/E 2025 | -0.19x |
|---|---|---|---|---|---|
| Enterprise Value | 68.12M 74.69M 62.98M 56.84M 107M 6.98B 111M 761M 301M 3.77B 280M 274M 11.9B | EV / Sales 2024 |
0.71x | EV / Sales 2025 | 0.68x |
| Free-Float |
40.35% | Yield 2024 * |
-
| Yield 2025 | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALBIO | Real-time | |
| 0DL | Delayed | ||
| 0DL | Delayed | ||
| 0DL | Real-time | ||
| Real-time | |||
| Real-time |
| 1 day | -0.74% | ||
| 1 week | -2.43% | ||
| Current month | -3.83% | ||
| 1 month | -3.83% | ||
| 3 months | -13.55% | ||
| 6 months | -13.55% | ||
| Current year | +34.90% |
| 1 week | 0.8 | 0.83 | |
| 1 month | 0.78 | 0.91 | |
| Current year | 0.56 | 1.57 | |
| 1 year | 0.46 | 1.57 | |
| 3 years | 0.46 | 8.97 | |
| 5 years | 0.46 | 28.78 | |
| 10 years | 0.46 | 30.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Larry Abensur
CEO | Chief Executive Officer | 71 | 2015-06-23 |
Thierry Paper
CTO | Chief Tech/Sci/R&D Officer | 63 | 2014-12-31 |
Oren Bitton
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Paper
BRD | Director/Board Member | 63 | 2015-06-23 |
Thomas Lamy
BRD | Director/Board Member | - | 2015-06-23 |
Larry Abensur
CHM | Chairman | 71 | 2015-06-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/15/23 | Buy | Director | 2,500 | 0.0244% | ||
| 2/15/23 | Buy | Director | 2,500 | 0.0244% | ||
| 2/28/22 | Buy | Chief Executive Officer | 2,000 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.74% | -2.43% | +51.70% | -89.41% | 16.45M | ||
| -0.16% | -4.54% | -19.75% | +3.09% | 181B | ||
| -1.67% | -1.04% | -0.25% | +33.78% | 125B | ||
| -0.01% | -0.31% | -11.60% | +9.86% | 121B | ||
| +1.12% | -0.96% | -41.94% | +2.39% | 90.52B | ||
| -0.84% | -0.58% | -3.81% | +77.53% | 66.9B | ||
| +0.40% | +0.76% | +12.39% | -7.49% | 58.68B | ||
| +1.49% | -0.42% | +4.39% | +47.94% | 54.38B | ||
| +0.86% | -0.15% | -1.84% | +38.65% | 48.46B | ||
| +0.84% | +4.77% | +3.97% | -1.08% | 35.4B | ||
| Average | +0.08% | -0.85% | -0.67% | +11.52% | 78B | |
| Weighted average by Cap. | -0.09% | -1.52% | -10.29% | +19.68% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 101M 111M 93.54M 84.41M 159M 10.37B 165M 1.13B 447M 5.6B 416M 407M 17.67B | 95.19M 104M 88.02M 79.43M 150M 9.75B 155M 1.06B 420M 5.26B 392M 383M 16.62B |
| Net income | -43.33M -47.51M -40.06M -36.16M -68.1M -4.44B -70.78M -484M -191M -2.4B -178M -175M -7.57B | -58.22M -63.84M -53.83M -48.58M -91.5M -5.97B -95.11M -650M -257M -3.22B -240M -234M -10.17B |
| Net Debt | 52.94M 58.04M 48.94M 44.17M 83.19M 5.42B 86.47M 591M 234M 2.93B 218M 213M 9.24B | 53.19M 58.32M 49.18M 44.38M 83.59M 5.45B 86.88M 594M 235M 2.94B 219M 214M 9.29B |
Employees
397
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-18 | €0.8040 | -0.74% | 7,021 |
| 26-11-17 | €0.8100 | -1.22% | 2,664 |
| 26-11-16 | €0.8200 | 0.00% | 4,128 |
| 26-11-13 | €0.8200 | -0.49% | 10,248 |
| 26-11-12 | €0.8240 | 0.00% | 6,027 |
- Stock Market
- Stocks
- ALBIO Stock
Select your edition
All financial news and data tailored to specific country editions
















